{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:34:02Z","timestamp":1768001642045,"version":"3.49.0"},"reference-count":70,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2016,10,2]]},"DOI":"10.1080\/10428194.2016.1195501","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T13:02:10Z","timestamp":1469624530000},"page":"2259-2267","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence"],"prefix":"10.1080","volume":"57","author":[{"given":"Claire N.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Talpaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09179.x"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29842"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.07.019"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404914"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-554634"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.119"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-537167"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000122"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.57"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2446"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.001"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.04.017"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.3863"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002028"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/284706"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245837"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-551929"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V124.21.406.406","volume":"124","author":"Tefferi A","year":"2014","journal-title":"Blood"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.233"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-015-0296-8"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood.V124.21.1834.1834","volume":"124","author":"Zarzour A","year":"2014","journal-title":"Blood"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.136"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328955"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-527903"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.4489"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12375"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S53348"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.092155"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.115840"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-485888"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V126.23.59.59","volume":"126","author":"Harrison CN","year":"2015","journal-title":"Blood"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-544411"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.119545"},{"key":"CIT0039","volume-title":"JAKAVI: summary of product characteristics","author":"European Medicines Agency","year":"2014"},{"key":"CIT0040","volume-title":"Jakafi (ruxolitinib) tablets [prescribing information]","author":"Incyte Corporation","year":"2014"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0653"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V120.21.2844.2844","volume":"120","author":"Barosi G","year":"2012","journal-title":"Blood"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1182\/blood.V122.21.5247.5247","volume":"122","author":"Alzate MA","year":"2013","journal-title":"Blood"},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.V122.21.1584.1584","volume":"122","author":"Jabbour E","year":"2013","journal-title":"Blood"},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood.V126.23.2799.2799","volume":"126","author":"Tavares R","year":"2015","journal-title":"Blood"},{"key":"CIT0046","unstructured":"Giraldo P, Palandri F, Palumbo GA, et\u00a0al Safety and efficacy of ruxolitinib (RUX) in patients with intermediate-1\u2013risk myelofibrosis (MF) from an open-label, multicenter, single-arm expanded-access study. Haematologica. 2015;100:265. Abstract n. P675."},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13379"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1302135"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/848473"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-81"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-482232"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.12.008"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.9490"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1200\/jco.2013.31.15_suppl.7030","volume":"31","author":"Kvasnicka HM","year":"2013","journal-title":"J Clin Oncol"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-635235"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095109"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2096-y"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1182\/blood.V124.21.1836.1836","volume":"124","author":"Al-Ali HK","year":"2014","journal-title":"Blood"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-633404"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12459"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-414631"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-015-0021-2"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-484642"},{"key":"CIT0064","first-page":"284168","volume":"2015","author":"Shamil E","year":"2015","journal-title":"Case Rep Infect Dis"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1604"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1186\/s12878-015-0029-1"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-204950"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.09.035"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.235"},{"key":"CIT0070","doi-asserted-by":"crossref","unstructured":"Passamonti F, Kiladjian J-J, Vannucchi AM, et\u00a0al. ReTHINK: a randomized, double-blind, placebo-controlled, multicenter, phase 3 study of ruxolitinib in early myelofibrosis patients with high molecular risk mutations. J Clin Oncol (suppl). 2016;34:TPS7080 (abstract).","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS7080"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/10428194.2016.1195501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2016.1195501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T23:35:23Z","timestamp":1656891323000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2016.1195501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,27]]},"references-count":70,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,7,5]]},"published-print":{"date-parts":[[2016,10,2]]}},"alternative-id":["10.1080\/10428194.2016.1195501"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2016.1195501","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}